Clinical trial
Clinical Investigation of Natural Killer Cells Treatment in Pneumonia Patients Infected With 2019 Novel Coronavirus
NCT04280224 is registered in ClinicalTrials.gov with Henan Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Investigation of Natural Killer Cells Treatment in Pneumonia Patients Infected With 2019 Novel Coronavirus
- Lead sponsor
- Henan Medical University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 15, 2020
- Completion date
- December 31, 2022
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
novel coronavirus pneumonia